• Users Online: 979
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Blocking pro-inflammatory platelet-activating factor receptors and activating cell survival pathways: A novel therapeutic strategy in experimental ischemic stroke

Belayev Ludmila, Obenaus Andre, Mukherjee Pranab K, Knott Eric J, Khoutorova Larissa, Reid Madigan M, Roque Cassia R, Nguyen Lawrence, Lee Jeong Bin, Petasis Nicos A, Oria Reinaldo B, Bazan Nicolas G

Year : 2020| Volume: 6| Issue : 4 | Page no: 260-268

   This article has been cited by
1 Xi-Xian-Tong-Shuan capsule alleviates vascular cognitive impairment in chronic cerebral hypoperfusion rats by promoting white matter repair, reducing neuronal loss, and inhibiting the expression of pro-inflammatory factors
Feng Yan, Yue Tian, Yuyou Huang, Qi Wang, Ping Liu, Ningqun Wang, Fangfang Zhao, Liyuan Zhong, Wuhan Hui, Yumin Luo
Biomedicine & Pharmacotherapy. 2022; 145: 112453
[Pubmed]  [Google Scholar] [DOI]
2 Synergistic neuroprotection by a PAF antagonist plus a docosanoid in experimental ischemic stroke: Dose-response and therapeutic window
Madigan M. Reid, Andre Obenaus, Pranab K. Mukherjee, Larissa Khoutorova, Cassia R. Roque, Nicos A. Petasis, Reinaldo B. Oria, Ludmila Belayev, Nicolas G. Bazan
Journal of Stroke and Cerebrovascular Diseases. 2022; 31(8): 106585
[Pubmed]  [Google Scholar] [DOI]
3 Systematic Understanding of Mechanism of Danggui Shaoyao San against Ischemic Stroke Using a Network Pharmacology Approach
Sijie Li, Yong Yang, Wei Zhang, Haiyan Li, Wantong Yu, Chen Gao, Jiali Xu, Wenbo Zhao, Changhong Ren, Feng Zhang
Evidence-Based Complementary and Alternative Medicine. 2022; 2022: 1
[Pubmed]  [Google Scholar] [DOI]
4 Potential Protective Effect of Dl-3-n-butylphthalide on Chronic Cerebral Ischemia Brain Injury
Fangfang Zhao, Yumin Luo
CNS & Neurological Disorders - Drug Targets. 2022; 21(9): 734
[Pubmed]  [Google Scholar] [DOI]
5 Combined Therapy With Avastin, a PAF Receptor Antagonist and a Lipid Mediator Inhibited Glioblastoma Tumor Growth
Valerie A. Cruz Flores,Hemant Menghani,Pranab K. Mukherjee,Luis Marrero,Andre Obenaus,Quan Dang,Larissa Khoutorova,Madigan M. Reid,Ludmila Belayev,Nicolas G. Bazan
Frontiers in Pharmacology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]


Read this article